Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-24 @ 5:44 PM
NCT ID:
NCT03048968
Eligibility Criteria:
Inclusion Criteria:
* Elderly adults
1. Age: between 65 and 84 years
2. elderly adults who had no neurological or musculoskeletal abnormalities affecting gait
3. Ability to walk at least 10m regardless of assist devices
* Stroke
1. Age: between 20 and 84 years
2. ≥ 3 months post stroke
3. Ability to walk at least 10m regardless of assist devices
4. Adequate gait function (FAC \> 3)
5. Physician approval for patient participation
Exclusion Criteria:
* Elderly adults
1. History of any diseases (eg. lower extremity orthopedic diseases, neurologic disorders, cardiovascular disease, heart failure, uncontrolled hypertension that affect walking capacity, efficiency, and endurance)
2. Severe visual impairment or dizziness that increases the risk of falls
* Stroke
1. Serious cardiac conditions (hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living)
2. Advanced liver, kidney, cardiac, or pulmonary disease
3. History of concussion in last 6 months
4. History of unexplained, recurring headaches, epilepsy/seizures/skull fractures or skull deficits
5. Preexisting neurological disorders such as Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), dementia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
84 Years
Study:
NCT03048968
Study Brief:
Protocol Section:
NCT03048968